Clinical Trial Update: Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients [Phase 4]

View source ↗

Summary

An ongoing Phase 4 trial is evaluating low-dose Tenecteplase for acute ischemic stroke in aging patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Acute Ischemic Stroke Patients | Phase 4 | Status: RECRUITING